Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Mapping Multi-Site Clinic Workflows to Design Systems-Enabled Interventions.

Coronado GD, Retecki S, Petrik AF, Coury J, Aguirre J, Taplin SH, Burdick T, Green BB.

EGEMS (Wash DC). 2017 Jun 14;5(1):13. doi: 10.5334/egems.219.

2.

Lay Beliefs About the Accuracy and Value of Cancer Screening.

Roberts MC, Ferrer RA, Rendle KA, Kobrin SC, Taplin SH, Hesse BW, Klein WMP.

Am J Prev Med. 2018 May;54(5):699-703. doi: 10.1016/j.amepre.2018.02.002. Epub 2018 Mar 16.

PMID:
29551327
3.

Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India.

Sivaram S, Majumdar G, Perin D, Nessa A, Broeders M, Lynge E, Saraiya M, Segnan N, Sankaranarayanan R, Rajaraman P, Trimble E, Taplin S, Rath GK, Mehrotra R.

Lancet Oncol. 2018 Feb;19(2):e113-e122. doi: 10.1016/S1470-2045(18)30003-2. Review.

PMID:
29413465
4.

Hepatotoxicity with antibody maytansinoid conjugates: A review of preclinical and clinical findings.

Taplin S, Vashisht K, Walles M, Calise D, Kluwe W, Bouchard P, Johnson R.

J Appl Toxicol. 2018 May;38(5):600-615. doi: 10.1002/jat.3582. Epub 2018 Feb 1. Review.

PMID:
29388692
5.

An Exploration of Changes in the Measurement of Mammography in the National Health Interview Survey.

Gonzales FA, Willis GB, Breen N, Yan T, Cronin KA, Taplin SH, Yu M.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1611-1618. doi: 10.1158/1055-9965.EPI-17-0213. Epub 2017 Sep 8.

PMID:
28887296
6.

Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics.

Coury J, Schneider JL, Rivelli JS, Petrik AF, Seibel E, D'Agostini B, Taplin SH, Green BB, Coronado GD.

BMC Health Serv Res. 2017 Jun 19;17(1):411. doi: 10.1186/s12913-017-2364-3.

7.

Geospatial Approaches to Cancer Control and Population Sciences.

Schootman M, Gomez SL, Henry KA, Paskett ED, Ellison GL, Oh A, Taplin SH, Tatalovich Z, Berrigan DA.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):472-475. doi: 10.1158/1055-9965.EPI-17-0104. Epub 2017 Mar 21.

8.

Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders.

Coronado GD, Schneider JL, Petrik A, Rivelli J, Taplin S, Green BB.

Transl Behav Med. 2017 Sep;7(3):557-566. doi: 10.1007/s13142-016-0461-1.

9.

Health Information Systems Approach to Managing Task Interdependence in Cancer Care Teams.

Chollette V, Beasley DD, Abdiwahab E, Taplin S.

J Oncol Pract. 2017 Mar;13(3):154-156. doi: 10.1200/JOP.2016.020156. Epub 2017 Jan 24. No abstract available.

PMID:
28118105
10.

Prenatal reporting to child protection: Characteristics and service responses in one Australian jurisdiction.

Taplin S.

Child Abuse Negl. 2017 Mar;65:68-76. doi: 10.1016/j.chiabu.2017.01.007. Epub 2017 Jan 21.

PMID:
28113086
11.

National Cancer Institute-American Society of Clinical Oncology Teams in Cancer Care Project.

Kosty MP, Hanley A, Chollette V, Bruinooge SS, Taplin SH.

J Oncol Pract. 2016 Nov;12(11):955-958. Epub 2016 Oct 24. No abstract available.

PMID:
27756798
12.

Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.

Leyva B, Persoskie A, Ottenbacher A, Hamilton JG, Allen JD, Kobrin SC, Taplin SH.

J Cancer Educ. 2016 Dec;31(4):693-701. doi: 10.1007/s13187-015-0870-8.

13.

Radiologists' interpretive skills in screening vs. diagnostic mammography: are they related?

Elmore JG, Cook AJ, Bogart A, Carney PA, Geller BM, Taplin SH, Buist DS, Onega T, Lee CI, Miglioretti DL.

Clin Imaging. 2016 Nov - Dec;40(6):1096-1103. doi: 10.1016/j.clinimag.2016.06.014. Epub 2016 Jul 1.

14.

Health Self-Efficacy Among Populations with Multiple Chronic Conditions: the Value of Patient-Centered Communication.

Finney Rutten LJ, Hesse BW, St Sauver JL, Wilson P, Chawla N, Hartigan DB, Moser RP, Taplin S, Glasgow R, Arora NK.

Adv Ther. 2016 Aug;33(8):1440-51. doi: 10.1007/s12325-016-0369-7. Epub 2016 Jun 29.

15.

Receipt of mammography recommendations among White and non-White women before and after the 2009 United States Preventive Services Task Force recommendation change.

Gonzales FA, Taplin SH, Yu M, Breen N, Cronin KA.

Cancer Causes Control. 2016 Aug;27(8):977-87. doi: 10.1007/s10552-016-0775-9. Epub 2016 Jun 28.

PMID:
27351918
16.

Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.

Johnson KE, Neta G, Dember LM, Coronado GD, Suls J, Chambers DA, Rundell S, Smith DH, Liu B, Taplin S, Stoney CM, Farrell MM, Glasgow RE.

Trials. 2016 Jan 16;17:32. doi: 10.1186/s13063-016-1158-y.

17.

Prescription opioid analgesics for pain management in Australia: 20 years of dispensing.

Islam MM, McRae IS, Mazumdar S, Taplin S, McKetin R.

Intern Med J. 2016 Aug;46(8):955-63. doi: 10.1111/imj.12966. Erratum in: Intern Med J. 2016 Aug;46(8):963.

PMID:
26602489
18.

KContact, an enhanced intervention for contact between children in out-of-home care and their parents: protocol for a cluster randomised controlled trial.

Taplin S, Bullen T, McArthur M, Humphreys C, Kertesz M, Dobbins T.

BMC Public Health. 2015 Nov 16;15:1134. doi: 10.1186/s12889-015-2461-3.

19.

The expanding role of primary care in cancer control.

Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, Fahey T, Grassi L, Grunfeld E, Gupta S, Hamilton W, Hiom S, Hunter D, Lyratzopoulos G, Macleod U, Mason R, Mitchell G, Neal RD, Peake M, Roland M, Seifert B, Sisler J, Sussman J, Taplin S, Vedsted P, Voruganti T, Walter F, Wardle J, Watson E, Weller D, Wender R, Whelan J, Whitlock J, Wilkinson C, de Wit N, Zimmermann C.

Lancet Oncol. 2015 Sep;16(12):1231-72. doi: 10.1016/S1470-2045(15)00205-3. Review.

PMID:
26431866
20.

Recruiting community health centers into pragmatic research: Findings from STOP CRC.

Coronado GD, Retecki S, Schneider J, Taplin SH, Burdick T, Green BB.

Clin Trials. 2016 Apr;13(2):214-22. doi: 10.1177/1740774515608122. Epub 2015 Sep 29.

21.

Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes.

Onega T, Goldman LE, Walker RL, Miglioretti DL, Buist DS, Taplin S, Geller BM, Hill DA, Smith-Bindman R.

J Med Screen. 2016 Mar;23(1):31-7. doi: 10.1177/0969141315595254. Epub 2015 Aug 11.

PMID:
26265482
22.

Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys.

Dudal S, Subramanian K, Flandre T, Law WS, Lowe PJ, Skerjanec A, Genin JC, Duval M, Piequet A, Cordier A, Jarai G, Van Heeke G, Taplin S, Krantz C, Jones S, Warren AP, Brennan FR, Sims J, Lloyd P.

MAbs. 2015;7(5):829-37. doi: 10.1080/19420862.2015.1060384.

23.

Misclassification of Breast Imaging Reporting and Data System (BI-RADS) Mammographic Density and Implications for Breast Density Reporting Legislation.

Gard CC, Aiello Bowles EJ, Miglioretti DL, Taplin SH, Rutter CM.

Breast J. 2015 Sep-Oct;21(5):481-9. doi: 10.1111/tbj.12443. Epub 2015 Jul 1.

24.

Teams and teamwork during a cancer diagnosis: interdependency within and between teams.

Taplin SH, Weaver S, Chollette V, Marks LB, Jacobs A, Schiff G, Stricker CT, Bruinooge SS, Salas E.

J Oncol Pract. 2015 May;11(3):231-8. doi: 10.1200/JOP.2014.003376. Epub 2015 Apr 14.

25.

Reviewing cancer care team effectiveness.

Taplin SH, Weaver S, Salas E, Chollette V, Edwards HM, Bruinooge SS, Kosty MP.

J Oncol Pract. 2015 May;11(3):239-46. doi: 10.1200/JOP.2014.003350. Epub 2015 Apr 14. Review.

26.

Sharing care to achieve the triple aim of health care delivery.

Taplin SH.

J Oncol Pract. 2014 Sep;10(5):306-7. doi: 10.1200/JOP.2014.000869. No abstract available.

PMID:
25232188
27.

International variation in management of screen-detected ductal carcinoma in situ of the breast.

Ponti A, Lynge E, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Mano MP, Kawai M, Scharpantgen A, Fracheboud J, Hofvind S, Vidal C, Ascunce N, Salas D, Bulliard JL, Segnan N, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Oct;50(15):2695-704. doi: 10.1016/j.ejca.2014.07.019. Epub 2014 Aug 19.

28.

Follow-up to abnormal cancer screening tests: considering the multilevel context of care.

Zapka JM, Edwards HM, Chollette V, Taplin SH.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1965-73. doi: 10.1158/1055-9965.EPI-14-0454. Epub 2014 Jul 29. Review.

29.

Effect of radiologists' diagnostic work-up volume on interpretive performance.

Buist DS, Anderson ML, Smith RA, Carney PA, Miglioretti DL, Monsees BS, Sickles EA, Taplin SH, Geller BM, Yankaskas BC, Onega TL.

Radiology. 2014 Nov;273(2):351-64. doi: 10.1148/radiol.14132806. Epub 2014 Jun 24.

30.

Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.

Coronado GD, Vollmer WM, Petrik A, Taplin SH, Burdick TE, Meenan RT, Green BB.

Contemp Clin Trials. 2014 Jul;38(2):344-9. doi: 10.1016/j.cct.2014.06.006. Epub 2014 Jun 14.

31.

The nature and extent of child protection involvement among heroin-using mothers in treatment: high rates of reports, removals at birth and children in care.

Taplin S, Mattick RP.

Drug Alcohol Rev. 2015 Jan;34(1):31-7. doi: 10.1111/dar.12165. Epub 2014 May 29.

PMID:
24890662
32.

Is religiosity associated with cancer screening? Results from a national survey.

Leyva B, Nguyen AB, Allen JD, Taplin SH, Moser RP.

J Relig Health. 2015 Jun;54(3):998-1013. doi: 10.1007/s10943-014-9843-1.

PMID:
24833158
33.

Cancer screening and genetics: a tale of two paradigms.

Hamilton JG, Edwards HM, Khoury MJ, Taplin SH.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):909-16. doi: 10.1158/1055-9965.EPI-13-1016. Epub 2014 Apr 4.

34.

Behavioral research in cancer prevention and control: a look to the future.

Klein WM, Bloch M, Hesse BW, McDonald PG, Nebeling L, O'Connell ME, Riley WT, Taplin SH, Tesauro G.

Am J Prev Med. 2014 Mar;46(3):303-11. doi: 10.1016/j.amepre.2013.10.004. Review.

35.

Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.

Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S; ICSN DCIS Working group.

Eur J Cancer. 2014 Jan;50(1):185-92. doi: 10.1016/j.ejca.2013.08.013. Epub 2013 Sep 13.

36.

Organizational leadership for building effective health care teams.

Taplin SH, Foster MK, Shortell SM.

Ann Fam Med. 2013 May-Jun;11(3):279-81. doi: 10.1370/afm.1506.

37.

Mothers in methadone treatment and their involvement with the child protection system: a replication and extension study.

Taplin S, Mattick RP.

Child Abuse Negl. 2013 Aug;37(8):500-10. doi: 10.1016/j.chiabu.2013.01.003. Epub 2013 Feb 19.

PMID:
23428166
38.

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population.

Kamineni A, Anderson ML, White E, Taplin SH, Porter P, Ballard-Barbash R, Malone K, Buist DS.

Cancer Causes Control. 2013 Feb;24(2):305-12. doi: 10.1007/s10552-012-0115-7. Epub 2012 Dec 7.

39.

Advancing collaborative research with 2-1-1 to reduce health disparities: challenges, opportunities, and recommendations.

Hall KL, Stipelman BA, Eddens KS, Kreuter MW, Bame SI, Meissner HI, Yabroff KR, Purnell JQ, Ferrer R, Ribisl KM, Glasgow R, Linnan LA, Taplin S, Fernández ME.

Am J Prev Med. 2012 Dec;43(6 Suppl 5):S518-28. doi: 10.1016/j.amepre.2012.09.026. No abstract available.

40.

Breast MRI use uncommon among U.S. women.

Miller JW, Sabatino SA, Thompson TD, Breen N, White MC, Ryerson AB, Taplin S, Ballard-Barbash R.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):159-66. doi: 10.1158/1055-9965.EPI-12-0967. Epub 2012 Nov 15.

41.

Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium.

Gierach GL, Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME.

J Natl Cancer Inst. 2012 Aug 22;104(16):1218-27. doi: 10.1093/jnci/djs327. Epub 2012 Aug 21.

42.

A multilevel research perspective on cancer care delivery: the example of follow-up to an abnormal mammogram.

Taplin SH, Yabroff KR, Zapka J.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1709-15. doi: 10.1158/1055-9965.EPI-12-0265. Epub 2012 Aug 21.

43.

Chronic Care Model implementation for cancer screening and follow-up in community health centers.

Haggstrom DA, Taplin SH, Monahan P, Clauser S.

J Health Care Poor Underserved. 2012 Aug;23(3 Suppl):49-66. doi: 10.1353/hpu.2012.0131.

PMID:
22864487
44.

Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services.

Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, Melillo S, Carvalho M, Taplin S, Bastani R, Rimer BK, Vernon SW, Melvin CL, Taylor V, Fernandez M, Glanz K; Community Preventive Services Task Force.

Am J Prev Med. 2012 Jul;43(1):97-118. doi: 10.1016/j.amepre.2012.04.009. Review.

PMID:
22704754
45.

Multilevel intervention research: lessons learned and pathways forward.

Clauser SB, Taplin SH, Foster MK, Fagan P, Kaluzny AD.

J Natl Cancer Inst Monogr. 2012 May;2012(44):127-33. doi: 10.1093/jncimonographs/lgs019.

46.

Summary of the multilevel interventions in health care conference.

Edwards HM, Taplin SH, Chollette V, Clauser SB, Prabhu Das I, Kaluzny AD.

J Natl Cancer Inst Monogr. 2012 May;2012(44):123-6. doi: 10.1093/jncimonographs/lgs018. No abstract available.

47.

Multilevel interventions: study design and analysis issues.

Cleary PD, Gross CP, Zaslavsky AM, Taplin SH.

J Natl Cancer Inst Monogr. 2012 May;2012(44):49-55. doi: 10.1093/jncimonographs/lgs010.

48.

Multilevel factors affecting quality: examples from the cancer care continuum.

Zapka J, Taplin SH, Ganz P, Grunfeld E, Sterba K.

J Natl Cancer Inst Monogr. 2012 May;2012(44):11-9. doi: 10.1093/jncimonographs/lgs005.

49.

Introduction: Understanding and influencing multilevel factors across the cancer care continuum.

Taplin SH, Anhang Price R, Edwards HM, Foster MK, Breslau ES, Chollette V, Prabhu Das I, Clauser SB, Fennell ML, Zapka J.

J Natl Cancer Inst Monogr. 2012 May;2012(44):2-10. doi: 10.1093/jncimonographs/lgs008.

50.

Screening colonoscopy in the US: attitudes and practices of primary care physicians.

Zapka J, Klabunde CN, Taplin S, Yuan G, Ransohoff D, Kobrin S.

J Gen Intern Med. 2012 Sep;27(9):1150-8. doi: 10.1007/s11606-012-2051-3. Epub 2012 Apr 27.

Supplemental Content

Loading ...
Support Center